FDA will hold a public meeting on April 12, 2010 to discuss the reauthorization of the Prescription Drug User Fee Act (PDUFA), which expires in 2012. Prior to entering negotiations with regulated industry, FDA is required to seek public comment on any issues relating to reauthorization of this legislation. FDA will accept written comments through May 12, 2010.